Review
doi: 10.1016/j.it.2020.11.004. Epub 2020 Dec 2.Succinate Receptor 1: An Emerging Regulator of Myeloid Cell Function in Inflammation
Affiliations
- PMID:33279412
- DOI: 10.1016/j.it.2020.11.004
Item in Clipboard
Review
Succinate Receptor 1: An Emerging Regulator of Myeloid Cell Function in Inflammation
Grzegorz Krzak et al. Trends Immunol.2021 Jan.
Display options
Format
Display options
Format
Abstract
The rapidly evolving area of immunometabolism has shed new light on the fundamental properties of products and intermediates of cellular metabolism (metabolites), highlighting their key signaling roles in cell-to-cell communication. Recent evidence identifies the succinate-succinate receptor 1 (SUCNR1) axis as an essential regulator of tissue homeostasis. Succinate signaling via SUCNR1 guides divergent responses in immune cells, which are tissue and context dependent. Herein, we explore the main cellular pathways regulated by the succinate-SUCNR1 axis and focus on the biology of SUCNR1 and its roles influencing the function of myeloid cells. Hence, we identify new therapeutic targets and putative therapeutic approaches aimed at resolving detrimental myeloid cell responses in tissues, including those occurring in the persistently inflamed central nervous system (CNS).
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
- Insight into SUCNR1 (GPR91) structure and function.Gilissen J, Jouret F, Pirotte B, Hanson J.Gilissen J, et al.Pharmacol Ther. 2016 Mar;159:56-65. doi: 10.1016/j.pharmthera.2016.01.008. Epub 2016 Jan 22.Pharmacol Ther. 2016.PMID:26808164Review.
- Rethinking succinate: an unexpected hormone-like metabolite in energy homeostasis.Fernández-Veledo S, Ceperuelo-Mallafré V, Vendrell J.Fernández-Veledo S, et al.Trends Endocrinol Metab. 2021 Sep;32(9):680-692. doi: 10.1016/j.tem.2021.06.003. Epub 2021 Jul 20.Trends Endocrinol Metab. 2021.PMID:34301438Review.
- Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development.Ortiz-Masiá D, Gisbert-Ferrándiz L, Bauset C, Coll S, Mamie C, Scharl M, Esplugues JV, Alós R, Navarro F, Cosín-Roger J, Barrachina MD, Calatayud S.Ortiz-Masiá D, et al.Cells. 2020 Apr 29;9(5):1104. doi: 10.3390/cells9051104.Cells. 2020.PMID:32365557Free PMC article.
- Type 2 diabetes and succinate: unmasking an age-old molecule.Fernández-Veledo S, Marsal-Beltran A, Vendrell J.Fernández-Veledo S, et al.Diabetologia. 2024 Mar;67(3):430-442. doi: 10.1007/s00125-023-06063-7. Epub 2024 Jan 5.Diabetologia. 2024.PMID:38182909Free PMC article.Review.
- SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes.van Diepen JA, Robben JH, Hooiveld GJ, Carmone C, Alsady M, Boutens L, Bekkenkamp-Grovenstein M, Hijmans A, Engelke UFH, Wevers RA, Netea MG, Tack CJ, Stienstra R, Deen PMT.van Diepen JA, et al.Diabetologia. 2017 Jul;60(7):1304-1313. doi: 10.1007/s00125-017-4261-z. Epub 2017 Apr 5.Diabetologia. 2017.PMID:28382382Free PMC article.
Cited by
- Targeting oncometabolism to maximize immunotherapy in malignant brain tumors.Bernstock JD, Kang KD, Klinger NV, Olsen HE, Gary S, Totsch SK, Ghajar-Rahimi G, Segar D, Thompson EM, Darley-Usmar V, Mott BT, Peruzzotti-Jametti L, Friedman GK.Bernstock JD, et al.Oncogene. 2022 May;41(19):2663-2671. doi: 10.1038/s41388-022-02312-y. Epub 2022 Apr 16.Oncogene. 2022.PMID:35430605Free PMC article.Review.
- Succinate at the Crossroad of Metabolism and Angiogenesis: Roles of SDH, HIF1α and SUCNR1.Atallah R, Olschewski A, Heinemann A.Atallah R, et al.Biomedicines. 2022 Dec 1;10(12):3089. doi: 10.3390/biomedicines10123089.Biomedicines. 2022.PMID:36551845Free PMC article.Review.
- Dietary succinate supplementation to maternal mice improves fetal brown adipose tissue development and thermogenesis of female offspring.Liu X, Chen Y, Zhao L, Tian Q, deAvila JM, Zhu MJ, Du M.Liu X, et al.J Nutr Biochem. 2022 Feb;100:108908. doi: 10.1016/j.jnutbio.2021.108908. Epub 2021 Nov 18.J Nutr Biochem. 2022.PMID:34801687Free PMC article.
- Extracellular Succinate: A Physiological Messenger and a Pathological Trigger.Wu KK.Wu KK.Int J Mol Sci. 2023 Jul 6;24(13):11165. doi: 10.3390/ijms241311165.Int J Mol Sci. 2023.PMID:37446354Free PMC article.Review.
- Succinate Mediates Tumorigenic Effectsvia Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas.Matlac DM, Hadrava Vanova K, Bechmann N, Richter S, Folberth J, Ghayee HK, Ge GB, Abunimer L, Wesley R, Aherrahrou R, Dona M, Martínez-Montes ÁM, Calsina B, Merino MJ, Schwaninger M, Deen PMT, Zhuang Z, Neuzil J, Pacak K, Lehnert H, Fliedner SMJ.Matlac DM, et al.Front Endocrinol (Lausanne). 2021 Mar 12;12:589451. doi: 10.3389/fendo.2021.589451. eCollection 2021.Front Endocrinol (Lausanne). 2021.PMID:33776908Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases